Immunome Entered Into a Definitive Asset Purchase Agreement With Ayala Pharmaceuticals to Acquire AL102 and Related Drug Candidate AL101 From Ayala >IMNM
Immunome Entered Into a Definitive Asset Purchase Agreement With Ayala Pharmaceuticals to Acquire AL102 and Related Drug Candidate AL101 From Ayala >IMNM
Immunome 与 Ayala Pharmicals 签订了最终资产购买协议,从 Ayala 收购 AL102 和相关候选药物 AL101 >IMNM
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册